A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
The global Drug-coated Balloon (DCB) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Drug-coated Balloon (DCB) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Drug-coated Balloon (DCB) market include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Drug-coated Balloon (DCB) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug-coated Balloon (DCB) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug-coated Balloon (DCB) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug-coated Balloon (DCB) market size, projected growth trends, production technologies, key applications, and end-use industries.
Drug-coated Balloon (DCB) Segment by Company
- Medtronic
- Boston Scientific
- Becton Dickinson
- Biotronik
- B. Braun
- Philips
- Abbott
- Eurocor
- Yinyi Biotech
- Lepu Medical
- Grand Pharma
- Acotec Scientific
- Shenqi Medical
- MicroPort
- Zylox-Tonbridge Medical
- Zhejiang Barty Medical
Drug-coated Balloon (DCB) Segment by Type
- Coronary DCB
- Peripheral DCB (FP)
- Peripheral DCB (BTK)
Drug-coated Balloon (DCB) Segment by Application
- Dialysis Access (AVF/AVG)
- Femoropopliteal (FP)
- Below-the-Knee (BTK)
Drug-coated Balloon (DCB) Segment by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Türkiye
- GCC Countries
Study Objectives
- To analyze and research the global Drug-coated Balloon (DCB) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
- To present the key manufacturers, sales, revenue, market share, and Recent Developments.
- To split the breakdown data by regions, type, manufacturers, and Application.
- To analyze the global and key regions Drug-coated Balloon (DCB) market potential and advantage, opportunity and challenge, restraints, and risks.
- To identify Drug-coated Balloon (DCB) significant trends, drivers, influence factors in global and regions.
- To analyze Drug-coated Balloon (DCB) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market.
- This report helps stakeholders to gain insights into which regions to target globally.
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Drug-coated Balloon (DCB) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug-coated Balloon (DCB) industry.
Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Drug-coated Balloon (DCB) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Drug-coated Balloon (DCB) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
